No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs17703233 |
chr11:17513147-17513148 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs565569844 |
chr11:17513154-17513155 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs532637276 |
chr11:17513206-17513207 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs551138619 |
chr11:17513219-17513220 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs146806423 |
chr11:17513224-17513225 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs547800613 |
chr11:17513263-17513264 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs566092514 |
chr11:17513271-17513272 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs140622425 |
chr11:17513278-17513279 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs535476814 |
chr11:17513350-17513351 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs6486374 |
chr11:17513389-17513390 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
11 |
rs56170308 |
chr11:17513407-17513408 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
12 |
rs556296301 |
chr11:17513423-17513424 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs6486375 |
chr11:17513426-17513427 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
14 |
rs6486376 |
chr11:17513446-17513447 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
15 |
rs113997306 |
chr11:17513452-17513453 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs145613390 |
chr11:17513475-17513476 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs540622991 |
chr11:17513511-17513512 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs559021820 |
chr11:17513530-17513531 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs577447642 |
chr11:17513558-17513559 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs6486377 |
chr11:17513563-17513564 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
21 |
rs563066216 |
chr11:17513600-17513601 |
Weak transcription Strong transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs138152519 |
chr11:17513606-17513607 |
Weak transcription Strong transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs541570333 |
chr11:17513634-17513635 |
Weak transcription Strong transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs202031224 |
chr11:17513676-17513677 |
Weak transcription Strong transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs527319899 |
chr11:17513677-17513678 |
Weak transcription Strong transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs552127092 |
chr11:17513772-17513773 |
Weak transcription Strong transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs536848882 |
chr11:17513797-17513798 |
Weak transcription Strong transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs187355935 |
chr11:17513800-17513801 |
Weak transcription Strong transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs4757533 |
chr11:17513815-17513816 |
Weak transcription Strong transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
30 |
rs549717127 |
chr11:17513827-17513828 |
Weak transcription Strong transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs568212738 |
chr11:17513836-17513837 |
Weak transcription Strong transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs535643702 |
chr11:17513878-17513879 |
Weak transcription Strong transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs553126987 |
chr11:17513884-17513885 |
Weak transcription Strong transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs575879316 |
chr11:17513889-17513890 |
Weak transcription Strong transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs12576915 |
chr11:17513943-17513944 |
Weak transcription Strong transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
36 |
rs541050971 |
chr11:17514066-17514067 |
Weak transcription Strong transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs566954697 |
chr11:17514120-17514121 |
Weak transcription Strong transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs533968169 |
chr11:17514155-17514156 |
Weak transcription Strong transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs143416621 |
chr11:17514189-17514190 |
Weak transcription Strong transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs559279502 |
chr11:17514190-17514191 |
Weak transcription Strong transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs556485978 |
chr11:17514215-17514216 |
Weak transcription Strong transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs148344738 |
chr11:17514237-17514238 |
Weak transcription Strong transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs4756895 |
chr11:17514252-17514253 |
Weak transcription Strong transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
44 |
rs527409985 |
chr11:17514255-17514256 |
Weak transcription Strong transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs559841166 |
chr11:17514294-17514295 |
Weak transcription Strong transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs917276 |
chr11:17514301-17514302 |
Weak transcription Strong transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
47 |
rs4756896 |
chr11:17514347-17514348 |
Weak transcription Strong transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
48 |
rs917277 |
chr11:17514365-17514366 |
Weak transcription Strong transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
49 |
rs4756897 |
chr11:17514392-17514393 |
Weak transcription Strong transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
50 |
rs377583924 |
chr11:17514417-17514418 |
Enhancers Weak transcription Strong transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|